Degrades synaptobrevin and thus prevents synaptic vesicle fusion with the axon terminal membrane
- Produced by C. Botulinum
Inhibit acetylcholinesterase (AChE) by binding to the enzyme’s active site. (5)
Use for Focal Dystonias, Torticollis, Achalasia, Strabismus, Blepharospasm, Pain Syndromes, Wrinkles, and Hyperhidrosis
Use for Myasthenia Gravis, Eaton-Lambert Syndrome or other muscles weakness disorders (4)
Use for Reversal of anticholinergic toxicity or induced surgical paralysis
Has direct cholinergic agonist effect at Nm receptors
Topical application of (blank, blank) to the cornea of the eye decreases intraocular pressure by facilitating the outflow of aqueous humor
AChE Inhibitor encountered as a toxin, used as an insecticide
AChE Inhibitor Used for Alzheimer’s Disease and Dementia
Stimulate Muscarinic Receptor Activity (Muscarinic Receptor Agonists)
Used to Diagnose Asthma
Methacholine
Muscarinic Receptor Agonist Used for Glaucoma
Muscarinic Receptor Agonist Used for Urinary Tract Motility
Muscarinic Receptor Agonists Used for Xerostomia in Sjogren’s Syndrome
Adverse Effects Include Dyspnea, Lightheadedness, pruritus and throat irritation
Stimulate opening of nicotinic ACh receptor channel and produce depolarization of the cell membrane (creates a depolarizing blockade)
Used to induce neuromuscular blockade in surgery and for intubation
Adverse Effects Include Muscle Rigidity, myalgia, and raised intraocular pressure
Muscarinic Receptor Antagonist used for Anticholinesterase Overdose, Bradycardia, Premedication for anesthetic, and Antidote to Mushroom Poisoning
Side Effects Include Raised Intraocular pressure, tachycardia, constipation, xerostomia, and blurred vision
Muscarinic Receptor Antagonist used for Motion Sickness, Nausea, and Vomiting delivered via transdermal patch
Muscarinic Receptor Antagonist Used for Peptic Ulcer Disease (PUD) and induced bradycardia
Muscarinic Receptor Antagonist Used for Asthma and COPD
Muscarinic Receptor Antagonist Used for Overactive Bladder and Urge Incontinence